These results demonstrate that the functional and biochemical properties of the HSP90A–TCL1A–AKT axis are conserved across multiple types of cancer cells and that HSP90A is an actionable target for controlling NANOGhigh human tumor cells. The gene discussed is AKT1; the disease is neoplasm.